The Canadian bleeding disorder treatment centres participed in a rigorous self-assessment of their services from November 2022 to February 2023. IT IS NOW TIME TO...
The 1st gene therapy for hemophilia B (factor IX deficiency) is currently undergoing an evaluation by Canadian health authorities. This review will determine whether or...
As the result of the latest actuarial study to the end of the year 2019, the Joint Committee announced in early 2021 that the Fund...
On Friday, June 30, Maia Meier and Craig Upshaw, longstanding CHS volunteers, will start their climb to the top of Mount Kilimanjaro. Both Maia and...
The CHS is deeply saddened to learn of the passing of Dr. Ronald George. We would like to offer our sincere condolences to his wife...